findmyKOL

Morton Rinder, MD

Basic profile

St. Luke's Hospital

ORCIDNone on fileNPI
RegionChesterfield, MO · MidwestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Morton Rinder is a Cardiology physician affiliated with St. Luke's Hospital. OpenAlex indexes 22 publications with 427 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22publications

Distinct works indexed by OpenAlex.

427citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
53companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

222 S Woods Mill Rd Ste 560
Chesterfield, MO 630173625

Telephone

144-858-7883

Provider last certified this registry record 28 Aug 2020.

View the NPPES registry record

Industry payments

53 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.8%
    Beta blocker25.7%
    Metoprolol Succinate40%Carvedilol28%Metoprolol Tartrate23%Sotalol4%Nebivolol Hcl2%Atenolol1%Labetalol Hcl1%
    Part D<11 patients
    Statin12.4%
    Rosuvastatin Calcium47%Atorvastatin Calcium38%Simvastatin8%Pravastatin Sodium6%Lovastatin2%
    Part D<11 patients

    + 21 more classes in this area

  • Blood & clotting

    23%
    Factor Xa inhibitor15.1%
    Eliquis71%Xarelto29%
    Part D307 patients
    P2Y12 inhibitor6.2%
    Clopidogrel93%Brilinta6%Prasugrel Hcl2%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    2.8%
    SGLT2 inhibitor1.2%
    Jardiance55%Farxiga46%
    Part D23 patients
    Potassium supplement1%
    Potassium Chloride100%
    Part D44 patients

    + 3 more classes in this area

Where care is delivered (Part B)54.5% facility · 45.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”